Belize vs Mongolia: Estimated antiretroviral therapy coverage among people living with HIV
Belize
47.0%
in 2025
Mongolia
42.0%
in 2025
Belize rank
129th
Mongolia rank
132nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Belize
- Mongolia
How they compare
Belize currently reports 47.0% against 42.0% in Mongolia, a difference of 5.0%.
That makes Belize's figure about 1.1 times Mongolia's.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Belize ahead.
Belize ranks 129th and Mongolia ranks 132nd of 143 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.7% | 0.7% | 10.0% | Belize |
| 2010s | 29.8% | 22.9% | 6.9% | Belize |
| 2020s | 41.8% | 39.3% | 2.5% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Belize or Mongolia?
- Belize, at 47.0% against 42.0% in Mongolia as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Belize and Mongolia?
- 5.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Mongolia?
- 26 years are reported by both, from 2000 to 2025.
- How do Belize and Mongolia rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Belize ranks 129th and Mongolia ranks 132nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.